Evidence map›Paper›PMID 28986900›Full record

ArticleThe journal of headache and pain2017

Patients' preferences for headache acute and preventive treatment.

Dimos D Mitsikostas, Ioanna Belesioti, Chryssa Arvaniti, Euthymia Mitropoulou, Christina Deligianni, Elina Kasioti, Theodoros Constantinidis, Manolis Dermitzakis, Michail Vikelis, Hellenic Headache Society

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The journal of headache and pain, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Neuromodulation for Chronic Daily Headache.Current pain and headache reports · 2022
    Review
  17. Article
  18. Article
  19. European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2021
    Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dimos D MitsikostasFirst Neurology Department, Aeginition Hospital, School of Medicine, National & Kapodistrian University of Athens, 72-74 V. Sofias' Avenue, 11528, Athens, Greece. dmitsikostas@med.uoa.gr.
Ioanna BelesiotiFirst Neurology Department, Aeginition Hospital, School of Medicine, National & Kapodistrian University of Athens, 72-74 V. Sofias' Avenue, 11528, Athens, Greece.
Chryssa ArvanitiSecond Neurology Department, Attikon Hospital, School of Medicine, National & Kapodistrian University of Athens, Athens, Greece.
Euthymia MitropoulouFirst Neurology Department, Aeginition Hospital, School of Medicine, National & Kapodistrian University of Athens, 72-74 V. Sofias' Avenue, 11528, Athens, Greece.
Christina DeligianniFirst Neurology Department, Aeginition Hospital, School of Medicine, National & Kapodistrian University of Athens, 72-74 V. Sofias' Avenue, 11528, Athens, Greece.
Elina KasiotiFirst Neurology Department, Aeginition Hospital, School of Medicine, National & Kapodistrian University of Athens, 72-74 V. Sofias' Avenue, 11528, Athens, Greece.
Theodoros ConstantinidisPrivate Headache Clinic, Korinthos, Greece.
Manolis DermitzakisDepartment of Neurology, "Geniki Kliniki" Euromedica, Thessaloniki, Greece.
Michail VikelisHeadache Clinic, Mediterraneo Hospital, Glyfada, Greece.
Hellenic Headache Society

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe aimed to explore patients' preferences for headache treatments with a self-administered questionnaire including the Q-No questionnaire for nocebo.

methodsQuestionnaires from 514 outpatients naïve to neurostimulation and monoclonal antibodies were collected.

resultsPatients assessed that the efficacy of a treatment is more important than safety or route of administration. They preferred to use an external neurostimulation device for both acute (67.1%) and preventive treatment (62.8%). Most patients preferred to take a pill (86%) than any other drug given parenterally for symptomatic pharmaceutical treatment. For preventive pharmaceutical treatment, most patients preferred to take a pill once per day (52%) compared to an injection either subcutaneously or intravenously each month (9% and 4%), or three months (15% and 11%). 56.6% of all participants scored more than 15 in Q-No questionnaire indicating potential nocebo behaviors that contributed significantly in their choices.

conclusionThese patient preferences along with efficacy and safety data may help physicians better choose the right treatment for the right person.

Indexed as

Surveys and QuestionnairesAdultAnalgesicsAntibodies, MonoclonalFemaleGreeceHeadacheHumansImplantable NeurostimulatorsInjections, SubcutaneousMaleMiddle AgedMigraine DisordersPatient PreferencePreventive MedicineYoung AdultAnalgesicsAntibodies, MonoclonalCluster headacheEquity of healthcareMigraineMonoclonal antibodiesNeurostimulationNoceboPatient-centerednessTension-type headache

Identifiers

PMID28986900
PMCPMC5630539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.